Abstract

The paper presents the results of treatment of 113 children with retinoblastoma who were treated at the Scientific Center of Pediatrics and Pediatric Surgery under the RBA-2003 program from 2013 to 2020. Verification of the diagnosis of retinoblastoma was carried out according to international criteria. When analyzing the results of the study, the overall survival rate of children with retinoblastoma was 79%. The therapeutic protocol is highly effective, allowing to obtain high rates of overall survival in the vast majority of patients. The effectiveness of treatment in stage I was 97%, in stage II-90%, in stage III-80%. Early detection of RB promotes early initiation of antitumor therapy, the survival rate of which is more than 90% (I degree - 97%, II degree - 90%). Keywords: retinoblastoma in children, early diagnosis, organ-preserving therapy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.